BRAVECTO® (fluralaner topical solution) for Cats 13.8-27.5 lbs
is the first and only U.S. flea and tick product that provides protection against the Asian longhorned tick and kills 100% of fleas within 8 hours. Vet-recommended and FDA-approved, just one dose provides 12 weeks* of protection. It’s no secret that cats aren't a fan of monthly treatments so reduce the stress of treating your cat and apply BRAVECTO once every 12 weeks*!
- Fast-acting, safe and easy treatment
- BRAVECTO Topical lasts nearly 3X longer than other monthly treatments
- Up to 12 weeks* of flea & tick protection with just 1 dose!
- Easy to use non-spill, Twist’n’Use™ applicator. Do not give orally.
- Available in three sizes based on your cat's weight
- Did you know.. indoor cats can get fleas and ticks too?!
- The first and only U.S. product with protection against the Asian longhorned tick for up to 12 weeks.
Discover BRAVECTO Plus (fluralaner and moxidectin topical solution) for Cats that protects against 5 types of parasites with 2x the convenience of monthly products. BRAVECTO also comes in a topical solution for dogs and is available by prescription only.
Proudly sourced directly from the manufacturer or their approved distributor. Guaranteed genuine and backed by the manufacturer.
BRAVECTO (fluralaner topical solution) for Cats:
The most commonly reported adverse reactions include vomiting, itching, diarrhea, hair loss, decreased appetite, lethargy, and scabs/ulcerated lesions. BRAVECTO Topical Solution for Cats has not been shown to be effective for 12-weeks' duration in kittens less than 6 months of age. BRAVECTO Topical Solution for Cats is not effective against American dog ticks beyond 8 weeks of dosing. For topical use only. Avoid oral ingestion. The safety of BRAVECTO Topical Solution for Cats has not been established in breeding, pregnant and lactating cats. Fluralaner is a member of the isoxazoline class. This class has been associated with neurologic adverse reactions including tremors, ataxia , and seizures. Neurologic adverse reactions have been reported in cats receiving isoxazoline class drugs, even in cats without a history of neurologic disorders. Use with caution in cats with a history of neurologic disorders.